Suppr超能文献

预测多发性内分泌肿瘤 2 型年轻患者甲状腺全切除术预后的因素:一项全国范围内的长期随访研究。

Factors predicting outcome of total thyroidectomy in young patients with multiple endocrine neoplasia type 2: a nationwide long-term follow-up study.

机构信息

Department of Surgery, University Medical Center Utrecht, Hpnr. G04.228, Heidelberglaan 100, 3584CX Utrecht, The Netherlands.

出版信息

World J Surg. 2010 Apr;34(4):852-60. doi: 10.1007/s00268-009-0370-2.

Abstract

BACKGROUND Multiple endocrine neoplasia type 2 (MEN 2) is caused by a RET mutation in chromosome 10. All MEN 2 patients develop medullary thyroid carcinoma (MTC). The age-related risk of MTC is associated with the type of RET mutation. Our aim was to identify prognostic factors associated with recurrent MTC in MEN 2 patients. METHODS In a nationwide case-control study, all patients who underwent total thyroidectomy in the Netherlands under the age of 20 years were classified into standard (1), high (2), or very high risk (3) for MTC based on RET-mutation type. Disease-free patients were compared with those with recurrent disease. RESULTS A total of 93 patients were included in the study. Sixty-six percent had MTC on histology, the youngest being 1 year old. Codon 634 was most affected. Sixteen (18%) patients had persistent or recurrent disease, one of whom died. Significantly associated determinants of outcome in univariate analysis were higher age at surgery, no age-appropriate prophylactic surgery according to risk level, elevated preoperative calcitonin levels, affected codon, and the presence of lymph node metastases at surgery. On multivariate analysis only age of surgery was the single independent factor associated with persistent disease. CONCLUSIONS Prophylactic thyroidectomy beyond the recommended age is associated with persistent/recurrent disease. In addition, codon 634 mutation is associated with a high risk of recurrence requiring early surgery for all these patients.

摘要

背景

多发性内分泌腺瘤病 2 型(MEN 2)是由 10 号染色体上的 RET 突变引起的。所有 MEN 2 患者都会发展为甲状腺髓样癌(MTC)。MTC 的年龄相关风险与 RET 突变类型有关。我们的目的是确定与 MEN 2 患者复发性 MTC 相关的预后因素。

方法

在一项全国范围内的病例对照研究中,根据 RET 突变类型,将所有在荷兰 20 岁以下接受全甲状腺切除术的患者分为标准(1)、高(2)或极高(3)风险 MTC。无疾病患者与复发病例进行比较。

结果

共纳入 93 例患者。66%的患者组织学上有 MTC,最小的为 1 岁。634 密码子受影响最大。16 例(18%)患者有持续性或复发性疾病,其中 1 例死亡。单因素分析中与结局显著相关的决定因素是手术时年龄较高、未根据风险水平进行适当年龄的预防性手术、术前降钙素水平升高、受影响的密码子和手术时存在淋巴结转移。多因素分析仅显示手术时的年龄是与持续性疾病相关的唯一独立因素。

结论

超出推荐年龄的预防性甲状腺切除术与持续性/复发性疾病有关。此外,634 密码子突变与高复发风险相关,所有这些患者都需要早期手术。

相似文献

2
Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
J Pediatr Surg. 1996 Jan;31(1):177-81; discussion 181-2. doi: 10.1016/s0022-3468(96)90343-7.
7
Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
N Engl J Med. 2005 Sep 15;353(11):1105-13. doi: 10.1056/NEJMoa043999.
8
When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?
Ann Surg Oncol. 2009 Aug;16(8):2237-44. doi: 10.1245/s10434-009-0524-3. Epub 2009 May 27.
9
Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
Clin Endocrinol (Oxf). 2005 Dec;63(6):636-41. doi: 10.1111/j.1365-2265.2005.02394.x.

引用本文的文献

1
MEN2: surgical precision in the era of precision medicine.
Endocr Relat Cancer. 2025 Jun 6;32(6). doi: 10.1530/ERC-24-0251. Print 2025 Jun 1.
2
Late-Onset Medullary Thyroid Cancer in a Patient with a Germline Codon C634R Mutation.
Diagnostics (Basel). 2021 Aug 11;11(8):1448. doi: 10.3390/diagnostics11081448.
4
Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma.
J Endocr Soc. 2018 Jul 13;2(8):933-943. doi: 10.1210/js.2018-00178. eCollection 2018 Aug 1.
5
Outcome of Treatment for Medullary Thyroid Carcinoma-a Single Centre Experience.
Indian J Surg Oncol. 2018 Mar;9(1):52-58. doi: 10.1007/s13193-017-0718-2. Epub 2017 Dec 8.
6
A large Chinese pedigree of multiple endocrine neoplasia type 2A with a novel C634Y/D707E germline mutation in exon 11.
Oncol Lett. 2017 Sep;14(3):3552-3558. doi: 10.3892/ol.2017.6583. Epub 2017 Jul 15.
10
Hereditary medullary thyroid cancer: age-appropriate thyroidectomy improves disease-free survival.
Ann Surg Oncol. 2013 May;20(5):1451-5. doi: 10.1245/s10434-012-2757-9. Epub 2012 Nov 29.

本文引用的文献

1
Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma.
World J Surg. 2007 May;31(5):957-68. doi: 10.1007/s00268-006-0769-y.
3
Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
N Engl J Med. 2005 Sep 15;353(11):1105-13. doi: 10.1056/NEJMoa043999.
4
Advances in the management of hereditary medullary thyroid cancer.
J Intern Med. 2005 Jan;257(1):50-9. doi: 10.1111/j.1365-2796.2004.01423.x.
7
Early malignant progression of hereditary medullary thyroid cancer.
N Engl J Med. 2003 Oct 16;349(16):1517-25. doi: 10.1056/NEJMoa012915.
9
Guidelines for diagnosis and therapy of MEN type 1 and type 2.
J Clin Endocrinol Metab. 2001 Dec;86(12):5658-71. doi: 10.1210/jcem.86.12.8070.
10
Treatment of medullary thyroid carcinoma: an update.
Endocr Relat Cancer. 2001 Jun;8(2):135-47. doi: 10.1677/erc.0.0080135.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验